# Does BRV Have Faster Onset Time & Greater Effect Than LEV in Epilepsy Pts Using PPR Pharmacodynamic Efficacy Endpoint

> **NCT03580707** · PHASE2,PHASE3 · COMPLETED · sponsor: **Rosenfeld, William E., M.D.** · enrollment: 16 (actual)

## Conditions studied

- Photosensitive Epilepsy

## Interventions

- **DRUG:** BRV vs LEV in randomized double blinded, crossover fashion

## Key facts

- **NCT ID:** NCT03580707
- **Lead sponsor:** Rosenfeld, William E., M.D.
- **Sponsor class:** INDIV
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-01
- **Primary completion:** 2018-12-31
- **Final completion:** 2018-12-31
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2019-03-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03580707

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03580707, "Does BRV Have Faster Onset Time & Greater Effect Than LEV in Epilepsy Pts Using PPR Pharmacodynamic Efficacy Endpoint". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03580707. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*